{"disease":{"id":"conversion-of-atrial-fibrillation-flutter","name":"Conversion of Atrial Fibrillation/Flutter","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"ibutilide","indication_name":"Rapid conversion of atrial fibrillation or atrial flutter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Corvert","generic_name":"IBUTILIDE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antiarrhythmic","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"tikosyn","indication_name":"Conversion of Atrial Fibrillation/Flutter","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tikosyn","generic_name":"Dofetilide","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"IKr potassium channel (rapid component of delayed rectifier potassium current)","drug_class":"Vaughan Williams Class III antiarrhythmic","quality_score":10,"revenue":null,"mechanism":"Blocks cardiac potassium channel IKr to prolong repolarization and delay arrhythmia recurrence."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[{"drug_id":"tikosyn","guideline_body":"FDA label","recommendation":"TIKOSYN is indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}